Added to YB: 2019-09-08
Pitch date: 2019-09-08
MRTX [bearish]
Mirati Therapeutics, Inc.
+33.68%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Mirati Therapeutics, Inc., a commercial-stage oncology company, develops novel therapeutics to address the genetic and immunological promoters of cancer in the United States.
Market Cap
$4.1B
Pitch Price
$88.51
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.23
P/E
-4.83
EV/Sales
83.51
Sector
Biotechnology
Category
N/A
Show full summary:
MIRATI THERAPEUTICS INC MRTX
A summary for this pitch has not been created yet.
Read full article (0 min)